The main objective of this study is to collect data on the long-term safety of azer-cel, primarily through the capture of clinical events of interest (CEI) for up to 15 years following participation in TG-Azercel -101 study.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Number of Participants With Clinically Significant CEI
Timeframe: Up to 15 years
Number of Participants With Clinically Significant CEI Based on Severity
Timeframe: Up to 15 years
Duration of Clinically Significant CEI
Timeframe: Up to 15 years
Time to Onset of Clinically Significant CEI
Timeframe: Up to 15 years
TG Therapeutics Clinical Support Team